O presente estudo avaliou uma intervenção do hábito de vida em pacientes com a alteração mais precoce desta cascata, a gastrite, e pôde-se observar que a alteração do pH da água ingerida por 4 meses foi capaz de melhorar a gastrite clinicamente, e parece ter uma tendência ao aumento de expressão de microRNAs considerados benéficos no processo de carcinogênese em câncer gástrico.
Desta forma, o atual estudo, serve como gerador de hipóteses e como questionamento sobre qual será o pH ideal das bebidas consumidas com regularidade como a água, podendo servir como base para estudos maiores e randomizados.
REFERÊNCIAS
ABÓS-HERRÀNDIZ, R. et al. Risk factors of mortality from all asbestos-
related diseases: a competing risk analysis. Canadian respiratory
journal, v. 2017, 2017. ISSN 1198-2241.
ANAUATE, A. C. et al. Identification of suitable reference genes for
miRNA expression normalization in gastric cancer. Gene, v. 621, p. 59-
68, 2017. ISSN 0378-1119.
ARIGONI, M. et al. miR-135b coordinates progression of ErbB2-driven
mammary carcinomas through suppression of MID1 and MTCH2. The
American journal of pathology, v. 182, n. 6, p. 2058-2070, 2013. ISSN
0002-9440.
AZZARITO, T. et al. Effect of modified alkaline supplementation on
syngenic melanoma growth in CB57/BL mice. PloS one, v. 11, n. 7, p.
e0159763, 2016. ISSN 1932-6203.
BANDRÉS, E. et al. Identification by Real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and non-
tumoral tissues. Molecular cancer, v. 5, n. 1, p. 29, 2006. ISSN 1476-
4598.
BARCHITTA, M. et al. LINE-1 hypomethylation in blood and tissue
samples as an epigenetic marker for cancer risk: a systematic review
and meta-analysis. PloS one, v. 9, n. 10, p. e109478, 2014. ISSN 1932-
6203.
BARSTAD, B. et al. Intake of wine, beer and spirits and risk of gastric
cancer. European journal of cancer prevention, v. 14, n. 3, p. 239-243,
2005. ISSN 0959-8278.
BARTEL, B.; BARTEL, D. P. MicroRNAs: at the root of plant development?
Plant physiology, v. 132, n. 2, p. 709-717, 2003. ISSN 0032-0889.
BARTEL, D. P. MicroRNAs: genomics, biogenesis, mechanism, and
function. cell, v. 116, n. 2, p. 281-297, 2004. ISSN 0092-8674.
BEASLEY, R. P. et al. Hepatocellular carcinoma and hepatitis B virus: a
prospective study of 22 707 men in Taiwan. The Lancet, v. 318, n. 8256,
p. 1129-1133, 1981. ISSN 0140-6736.
BHUJWALLA, Z. et al. Combined vascular and extracellular pH imaging
of solid tumors. NMR in Biomedicine: An International Journal Devoted
to the Development and Application of Magnetic Resonance In Vivo, v.
15, n. 2, p. 114-119, 2002. ISSN 0952-3480.
BI, Y. et al. MicroRNA-7 functions as a tumor-suppressor gene by
regulating ILF2 in pancreatic carcinoma. International journal of
molecular medicine, v. 39, n. 4, p. 900-906, 2017. ISSN 1107-3756.
BRASIL, M. D. S. Portaria nº 2.194, de 12 de dezembro de 2011. Brasília,
DF, 2011.
BRUSSELAERS, N. et al. Maintenance therapy with proton pump
inhibitors and risk of gastric cancer: a nationwide population-based
cohort study in Sweden. BMJ open, v. 7, n. 10, p. e017739, 2017. ISSN
2044-6055.
CAIRNS, R.; PAPANDREOU, I.; DENKO, N. Overcoming physiologic
barriers to cancer treatment by molecularly targeting the tumor
microenvironment. Molecular Cancer Research, v. 4, n. 2, p. 61-70,
2006. ISSN 1541-7786.
CAO, D. et al. Canolol inhibits gastric tumors initiation and progression
through COX-2/PGE2 pathway in K19-C2mE transgenic mice. PLoS One,
v. 10, n. 3, p. e0120938, 2015. ISSN 1932-6203.
CASTLE, P. E. et al. A prospective study of high-grade cervical neoplasia
risk among human papillomavirus-infected women. Journal of the
National Cancer Institute, v. 94, n. 18, p. 1406-1414, 2002. ISSN 1460-
2105.
CHANG, Y.-L. et al. MicroRNA-7 inhibits the stemness of prostate
cancer
stem-like
cells
and
tumorigenesis
by
repressing
KLF4/PI3K/Akt/p21 pathway. Oncotarget, v. 6, n. 27, p. 24017, 2015.
CHEN, A. et al. Activation of GPR4 by acidosis increases endothelial cell
adhesion through the cAMP/Epac pathway. PloS one, v. 6, n. 11, p.
e27586, 2011. ISSN 1932-6203.
CHEN, W.-Q. et al. Role of microRNA-7 in digestive system malignancy.
World journal of gastrointestinal oncology, v. 8, n. 1, p. 121, 2016.
CHEUNG, K. S. et al. Long-term proton pump inhibitors and risk of
gastric cancer development after treatment for Helicobacter pylori: a
population-based study. Gut, v. 67, n. 1, p. 28-35, 2018. ISSN 0017-
5749.
CORREA, P. Human gastric carcinogenesis: a multistep and
multifactorial process—first American Cancer Society award lecture on
cancer epidemiology and prevention. Cancer research, v. 52, n. 24, p.
6735-6740, 1992. ISSN 0008-5472.
COTRAN, R.; KUMAR, V.; COLLINS, T. Red cells and bleeding disorders.
Robbins Pathologic Basis of Disease (6th edition). WB Saunders
Company, Philadelphia, p. 638-640, 1999.
CRAVO, M. et al. Global DNA hypomethylation occurs in the early
stages of gastric carcinogenesis. Gastroenterology, v. 108, n. 4, p. A458,
1995. ISSN 0016-5085.
DIPPOLD, R. P. et al. Chronic Ethanol Feeding Alters mi RNA Expression
Dynamics During Liver Regeneration. Alcoholism: Clinical and
Experimental Research, v. 37, p. E59-E69, 2013. ISSN 0145-6008.
DONG, C. et al. Low miR-29c expression is a prognostic marker in
hepatocellular carcinoma. Genet Mol Res, v. 15, n. 3, 2016.
DONG, L. et al. Acidosis activation of the proton-sensing GPR4 receptor
stimulates vascular endothelial cell inflammatory responses revealed
by transcriptome analysis. PloS one, v. 8, n. 4, p. e61991, 2013. ISSN
1932-6203.
DUBOIS, R. N. et al. Cyclooxygenase in biology and disease. The FASEB
journal, v. 12, n. 12, p. 1063-1073, 1998. ISSN 0892-6638.
DUDDA, J. C. et al. MicroRNA-155 is required for effector CD8+ T cell
responses to virus infection and cancer. Immunity, v. 38, n. 4, p. 742-
753, 2013. ISSN 1074-7613.
FANG, Y. et al. MicroRNA‐7 inhibits tumor growth and metastasis by
targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular
carcinoma. Hepatology, v. 55, n. 6, p. 1852-1862, 2012. ISSN 1527-
3350.
FENTON, T. R.; HUANG, T. Systematic review of the association between
dietary acid load, alkaline water and cancer. BMJ open, v. 6, n. 6, p.
e010438, 2016. ISSN 2044-6055.
FERLAY, J. et al. Global cancer statistics. CA: a cancer journal for
clinicians, v. 61, n. 2, p. 69-90, 2012. ISSN 0007-9235.
FERLAY, J. et al. Lyon, France: International Agency for Research on
Cancer; 2013. Cancer Incidence and Mortality Worldwide: IARC
CancerBase, n. 10, 2012.
FISCHER, B. et al. Acidic pH inhibits non-MHC-restricted killer cell
functions. Clinical Immunology, v. 96, n. 3, p. 252-263, 2000. ISSN 1521-
6616.
GATENBY, R. A.; GILLIES, R. J. Why do cancers have high aerobic
glycolysis? Nature Reviews Cancer, v. 4, n. 11, p. 891, 2004. ISSN 1474-
1768.
GILES, K. M. et al. microRNA-7-5p inhibits melanoma cell proliferation
and metastasis by suppressing RelA/NF-κB. Oncotarget, v. 7, n. 22, p.
31663, 2016.
GUO, J. et al. Genomic landscape of gastric cancer: molecular
classification and potential targets. Science China Life Sciences, v. 60, n.
2, p. 126-137, 2017. ISSN 1674-7305.
HAMMOND, S. M. An overview of microRNAs. Advanced drug delivery
reviews, v. 87, p. 3-14, 2015. ISSN 0169-409X.
HAN, T.-S. et al. MicroRNA-29c mediates initiation of gastric
carcinogenesis by directly targeting ITGB1. Gut, v. 64, n. 2, p. 203-214,
2015. ISSN 0017-5749.
HANAHAN, D.; WEINBERG, R. A. Hallmarks of cancer: the next
generation. cell, v. 144, n. 5, p. 646-674, 2011. ISSN 0092-8674.
HARDMAN, J.; LIMBIRD, L. Goodman e Gilman: As bases farmacológicas
da terapêutica. 10ª edição. Mc Grawltil, v. 65, p. 1349-1351, 2003.
HEINZELMANN, J. et al. Specific miRNA signatures are associated with
metastasis and poor prognosis in clear cell renal cell carcinoma. World
journal of urology, v. 29, n. 3, p. 367-373, 2011. ISSN 0724-4983.
HELMLINGER, G. et al. Acid production in glycolysis-impaired tumors
provides new insights into tumor metabolism. Clinical Cancer Research,
v. 8, n. 4, p. 1284-1291, 2002. ISSN 1078-0432.
HIGGS, G.; SLACK, F. The multiple roles of microRNA-155 in
oncogenesis. Journal of clinical bioinformatics, v. 3, n. 1, p. 17, 2013.
ISSN 2043-9113.
HUFFAKER, T. B. et al. Epistasis between microRNAs 155 and 146a
during T cell-mediated antitumor immunity. Cell reports, v. 2, n. 6, p.
1697-1709, 2012. ISSN 2211-1247.
HUMANS, I. W. G. O. T. E. O. C. R. T. Schistosomes, liver flukes and
Helicobacter pylori. International Agency for Research on Cancer,
1994. ISBN 9283212614.
HUNT, R. H. Importance of pH control in the management of GERD.
Archives of internal medicine, v. 159, n. 7, p. 649-657, 1999. ISSN 0003-
9926.
HWANG, H.; DWYER, J.; RUSSELL, R. M. Diet, Helicobacter pylori
infection, food preservation and gastric cancer risk: are there new roles
for preventative factors? Nutrition reviews, v. 52, n. 3, p. 75-83, 1994.
ISSN 1753-4887.
INCA.
Estômago.
Brasil,
2018.
Disponível
em:
<
http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home
/estomago/definicao >. Acesso em: 02/09/2018.
IRIMIE, A. I. et al. Current Insights into Oral Cancer Epigenetics.
International journal of molecular sciences, v. 19, n. 3, p. 670, 2018.
ISHIMOTO, T. et al. Current perspectives toward the identification of
key players in gastric cancer micro RNA dysregulation. International
journal of cancer, v. 138, n. 6, p. 1337-1349, 2016. ISSN 0020-7136.
JASIULIONIS, M. G. Abnormal epigenetic regulation of immune system
during aging. Frontiers in immunology, v. 9, p. 197, 2018. ISSN 1664-
3224.
JIANG, S. et al. MicroRNA-155 functions as an OncomiR in breast cancer
by targeting the suppressor of cytokine signaling 1 gene. Cancer
research, p. 0008-5472. CAN-09-4250, 2010. ISSN 0008-5472.
JOHNSON, C. M. et al. Meta-analyses of colorectal cancer risk factors.
Cancer causes & control, v. 24, n. 6, p. 1207-1222, 2013. ISSN 0957-
5243.
JUSTUS, C. R.; DONG, L.; YANG, L. V. Acidic tumor microenvironment
and pH-sensing G protein-coupled receptors. Frontiers in physiology, v.
4, p. 354, 2013. ISSN 1664-042X.
KAEMMERER, E. et al. Molecular classification of colorectal
carcinomas: the genotype-to-phenotype relation. World Journal of
Gastroenterology: WJG, v. 19, n. 45, p. 8163, 2013.
KANHERKAR, R. R.; BHATIA-DEY, N.; CSOKA, A. B. Epigenetics across the
human lifespan. Frontiers in cell and developmental biology, v. 2, p. 49,
2014. ISSN 2296-634X.
KEFAS, B. et al. microRNA-7 inhibits the epidermal growth factor
receptor and the Akt pathway and is down-regulated in glioblastoma.
Cancer research, v. 68, n. 10, p. 3566-3572, 2008. ISSN 0008-5472.
KIEC-WILK, B. et al. DNA methylation, induced by beta-carotene and
arachidonic acid, plays a regulatory role in the pro-angiogenic VEGF-
receptor (KDR) gene expression in endothelial cells. J Physiol Pharmacol,
v. 60, n. 4, p. 49-53, 2009.
KIM, V. N.; NAM, J.-W. Genomics of microRNA. TRENDS in Genetics, v.
22, n. 3, p. 165-173, 2006. ISSN 0168-9525.
KISHINO, M.; NAKAMURA, S.; SHIRATORI, K. Clinical and Endoscopic
Features of Undifferentiated Gastric Cancer in Patients with Severe
Atrophic Gastritis. Internal Medicine, v. 55, n. 8, p. 857-862, 2016. ISSN
0918-2918.
KONG, D. et al. Inflammation-induced repression of tumor suppressor
miR-7 in gastric tumor cells. Oncogene, v. 31, n. 35, p. 3949, 2012. ISSN
1476-5594.
KONTUREK, S. New aspects of clinical pharmacology of antacids. Journal
of physiology and pharmacology: an official journal of the Polish
Physiological Society, v. 44, n. 3 Suppl 1, p. 5-21, 1993. ISSN 0867-5910.
KOUFMAN, J. A.; JOHNSTON, N. Potential benefits of pH 8.8 alkaline
drinking water as an adjunct in the treatment of reflux disease. Annals
of Otology, Rhinology & Laryngology, v. 121, n. 7, p. 431-434, 2012. ISSN
0003-4894.
KRÜTZFELDT, J.; POY, M. N.; STOFFEL, M. Strategies to determine the
biological function of microRNAs. Nature genetics, v. 38, p. S14, 2006.
ISSN 1546-1718.
KUPCINSKAS, J. et al. Gene polymorphisms of micrornas in Helicobacter
pylori-induced high risk atrophic gastritis and gastric cancer. PloS one,
v. 9, n. 1, p. e87467, 2014. ISSN 1932-6203.
LADEIRAS-LOPES, R. et al. Smoking and gastric cancer: systematic
review and meta-analysis of cohort studies. Cancer causes & control, v.
19, n. 7, p. 689-701, 2008. ISSN 0957-5243.
LAGERGREN, J. et al. Symptomatic gastroesophageal reflux as a risk
factor for esophageal adenocarcinoma. New England journal of
medicine, v. 340, n. 11, p. 825-831, 1999. ISSN 0028-4793.
LAUBY-SECRETAN, B. et al. Body fatness and cancer—viewpoint of the
IARC Working Group. New England Journal of Medicine, v. 375, n. 8, p.
794-798, 2016. ISSN 0028-4793.
LEE, H.-J. et al. The role of chronic inflammation in the development of
gastrointestinal cancers: reviewing cancer prevention with natural anti-
inflammatory intervention. Expert review of gastroenterology &
hepatology, v. 10, n. 1, p. 129-139, 2016. ISSN 1747-4124.
LEVATI, L. et al. MicroRNA‐155 targets the SKI gene in human
melanoma cell lines. Pigment cell & melanoma research, v. 24, n. 3, p.
538-550, 2011. ISSN 1755-1471.
LI, C.-L. et al. microRNA-155 is downregulated in gastric cancer cells
and involved in cell metastasis. Oncology reports, v. 27, n. 6, p. 1960-
1966, 2012. ISSN 1021-335X.
LI, H. et al. The clinical significance of downregulation of mir-124-3p,
mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer
tumorigenesis. International journal of oncology, v. 45, n. 1, p. 197-208,
2014. ISSN 1019-6439.
LI, J. et al. Up-regulated miR-29c inhibits cell proliferation and glycolysis
by inhibiting SLC2A3 expression in prostate cancer. Gene, v. 665, p. 26-
34, 2018. ISSN 0378-1119.
LI, S. et al. The tumor suppressor role of miR‑ 155‑ 5p in gastric cancer.
Oncology letters, v. 16, n. 2, p. 2709-2714, 2018. ISSN 1792-1074.
LI, W. et al. miR-29c plays a suppressive role in breast cancer by
targeting the TIMP3/STAT1/FOXO1 pathway. Clinical epigenetics, v. 10,
n. 1, p. 64, 2018. ISSN 1868-7083.
LIN, C.-W. et al. MicroRNA-135b promotes lung cancer metastasis by
regulating multiple targets in the Hippo pathway and LZTS1. Nature
communications, v. 4, p. 1877, 2013. ISSN 2041-1723.
LIU, J. et al. MicroRNA-155 acts as a tumor suppressor in colorectal
cancer by targeting CTHRC1 in vitro. Oncology letters, v. 15, n. 4, p.
5561-5568, 2018. ISSN 1792-1074.
LIU, Z. et al. Up-regulated microRNA-146a negatively modulate
Helicobacter pylori-induced inflammatory response in human gastric
epithelial cells. Microbes and Infection, v. 12, n. 11, p. 854-863, 2010.
ISSN 1286-4579.
LIU, Z. et al. The tumor-suppressive microRNA-135b targets c-myc in
osteoscarcoma. PloS one, v. 9, n. 7, p. e102621, 2014. ISSN 1932-6203.
LOPES, C. B. et al. Differential expression of hsa-miR-221, hsa-miR-21,
hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer.
BMC cancer, v. 18, n. 1, p. 721, 2018. ISSN 1471-2407.
LU, C. et al. MiR-221 and miR-155 regulate human dendritic cell
development, apoptosis and IL-12 production through targeting of
p27kip1, KPC1 and SOCS-1. Blood, p. blood-2010-12-322503, 2011.
ISSN 0006-4971.
LU, M. et al. miR-135b-5p promotes gastric cancer progression by
targeting CMTM3. International journal of oncology, v. 52, n. 2, p. 589-
598, 2018. ISSN 1019-6439.
LU, Y. et al. MiR-29c inhibits cell growth, invasion, and migration of
pancreatic cancer by targeting ITGB1. OncoTargets and therapy, v. 9, p.
99, 2016.
LYRATZOPOULOS, G. Markers and measures of timeliness of cancer
diagnosis after symptom onset: a conceptual framework and its
implications. Cancer epidemiology, v. 38, n. 3, p. 211, 2014. ISSN 1877-
7821.
MAGRO, M. et al. Alkaline Water and Longevity: A Murine Study.
Evidence-Based Complementary and Alternative Medicine, v. 2016,
2016. ISSN 1741-427X.
MARTÍNEZ, D. et al. Extracellular acidosis induces neutrophil activation
by a mechanism dependent on activation of phosphatidylinositol 3-
kinase/Akt and ERK pathways. The Journal of Immunology, v. 176, n. 2,
p. 1163-1171, 2006. ISSN 0022-1767.
MATOBA, S. et al. p53 regulates mitochondrial respiration. Science, v.
312, p. 1650-1653, 2006.
MATSUDAI, N. M.; MAIAII, C. C.; DE ALMEIDA TRONCONIII, L. E.
Dispepsia funcional: revisão de diagnóstico e fisiopatologia. Cultura, v.
77, n. 92, p. 100, 2010.
MATSUO, M. et al. MiR-29c is downregulated in gastric carcinomas and
regulates cell proliferation by targeting RCC2. Molecular cancer, v. 12,
n. 1, p. 15, 2013. ISSN 1476-4598.
MCCARTY, M. F.; WHITAKER, J. Manipulating tumor acidification as a
cancer treatment strategy. Altern Med Rev, v. 15, n. 3, p. 264-72, 2010.
MEUNIER, P. J. et al. Consumption of a high calcium mineral water
lowers biochemical indices of bone remodeling in postmenopausal
women with low calcium intake. Osteoporosis international, v. 16, n. 10,
p. 1203-1209, 2005. ISSN 0937-941X.
MOUSA, H. A.-L. Health Effects of Alkaline Diet and Water, Reduction of
Digestive-tract Bacterial Load, and Earthing. Alternative Therapies in
Health & Medicine, v. 22, 2016. ISSN 1078-6791.
NAITO, Y. et al. Chronic administration with electrolyzed alkaline water
inhibits aspirin-induced gastric mucosal injury in rats through the
inhibition of tumor necrosis factor-α expression. Journal of clinical
biochemistry and nutrition, v. 32, p. 69-81, 2002. ISSN 0912-0009.
NIU, M. et al. MiR-29c regulates the expression of miR-34c and miR-
449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal
carcinoma. BMC cancer, v. 16, n. 1, p. 218, 2016. ISSN 1471-2407.
O'CONNELL, R. M. et al. MicroRNA-155 is induced during the
macrophage inflammatory response. Proceedings of the National
Academy of Sciences, v. 104, n. 5, p. 1604-1609, 2007. ISSN 0027-8424.
OSHIMA, A. A critical review of cancer screening programs in Japan.
International journal of technology assessment in health care, v. 10, n.
3, p. 346-358, 1994. ISSN 1471-6348.
OSTHUS, R. C. et al. Deregulation of glucose transporter 1 and glycolytic
gene expression by c-Myc. Journal of Biological Chemistry, v. 275, n. 29,
p. 21797-21800, 2000. ISSN 0021-9258.
PELETEIRO, B. Risk Factors for Gastric Intestinal Metaplasia. ARQUIVOS
DE MEDICINA-PORTO-, v. 20, n. 4, p. 115, 2006. ISSN 0871-3413.
PINTO, A. C. R. Helicobacter pylori: uma revisão. São Paulo: Centro
Universitário das Faculdades Metropolitanas Unidas, 2007.
QU, Y.-L. et al. Up-regulated miR-155-5p promotes cell proliferation,
invasion and metastasis in colorectal carcinoma. International journal of
clinical and experimental pathology, v. 8, n. 6, p. 6988, 2015.
RESENDE, A. L. D. S.; KOIFMAN, S.; MATTOS, I. E. Dieta e câncer gástrico:
aspectos históricos associados ao padrão de consumo alimentar no
Estado do Pará. Rev. nutr, p. 511-519, 2006.
RIBEIRO-DOS-SANTOS, Â. et al. Ultra-deep sequencing reveals the
microRNA expression pattern of the human stomach. PloS one, v. 5, n.
10, p. e13205, 2010. ISSN 1932-6203.
RICARTE FILHO, J.; KIMURA, E. T. MicroRNAs: nova classe de
reguladores gênicos envolvidos na função endócrina e câncer. Arq Bras
Endocrinol Metabol, v. 50, n. 6, p. 1102-1107, 2006. ISSN 0004-2730.
RODRIGUES, E. D. S. F. Águas Envasadas: Características Físico-Química,
Processo de Produção E Comercialização no Nordeste Paraense 2012.
SAITO, N. et al. An annexin A1–FPR1 interaction contributes to
necroptosis of keratinocytes in severe cutaneous adverse drug
reactions. Science translational medicine, v. 6, n. 245, p. 245ra95-
245ra95, 2014. ISSN 1946-6234.
SCHÄFER, M.; WERNER, S. Cancer as an overhealing wound: an old
hypothesis revisited. Nature reviews Molecular cell biology, v. 9, n. 8, p.
628, 2008. ISSN 1471-0080.
SCHORNACK, P. A.; GILLIES, R. J. Contributions of cell metabolism and
H+ diffusion to the acidic pH of tumors. Neoplasia, v. 5, n. 2, p. 135-145,
2003. ISSN 1476-5586.
SHAO, L. et al. Helicobacter pylori-induced miR-135b-5p promotes
cisplatin resistance in gastric cancer. The FASEB Journal, p. fj.
201701456RR, 2018. ISSN 0892-6638.
SHERMAN, H.; GETTLER, A. O. The balance of acid-forming and base-
forming elements in foods, and its relation to ammonia metabolism.
Journal of Biological Chemistry, v. 11, n. 4, p. 323-338, 1912. ISSN 0021-
9258.
SHIM, H. et al. c-Myc transactivation of LDH-A: implications for tumor
metabolism and growth. Proceedings of the National Academy of
Sciences, v. 94, n. 13, p. 6658-6663, 1997. ISSN 0027-8424.
SILVA, F. M. Dispepsia: caracterização e abordagem. Revista de
Medicina, v. 87, n. 4, p. 213-223, 2008. ISSN 1679-9836.
SMITH, W. L.; GARAVITO, R. M.; DEWITT, D. L. Prostaglandin
endoperoxide H synthases (cyclooxygenases)-1 and− 2. Journal of
Biological Chemistry, v. 271, n. 52, p. 33157-33160, 1996. ISSN 0021-
9258.
SONG, H. et al. Incidence of gastric cancer among patients with gastric
precancerous lesions: observational cohort study in a low risk Western
population. Bmj, v. 351, p. h3867, 2015. ISSN 1756-1833.
SUN, D.-M. et al. MiR-29c reduces the cisplatin resistance of non-small
cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
Scientific reports, v. 8, 2018.
SUTO, T. et al. MicroRNA-7 expression in colorectal cancer is associated
with poor prognosis and regulates cetuximab sensitivity via EGFR
regulation. Carcinogenesis, v. 36, n. 3, p. 338-345, 2015. ISSN 0143-
3334.
SWIETACH, Á. et al. New insights into the physiological role of carbonic
anhydrase IX in tumour pH regulation. Oncogene, v. 29, n. 50, p. 6509,
2010. ISSN 1476-5594.
TRAN-DUY, A. et al. Use of proton pump inhibitors and risks of fundic
gland polyps and gastric cancer: systematic review and meta-analysis.
Clinical Gastroenterology and Hepatology, v. 14, n. 12, p. 1706-1719. e5,
2016. ISSN 1542-3565.
TSUGANE, S.; SASAZUKI, S. Diet and the risk of gastric cancer: review of
epidemiological evidence. Gastric cancer, v. 10, n. 2, p. 75-83, 2007.
ISSN 1436-3291.
UMANSKY, V.; SEVKO, A. Tumor microenvironment and myeloid-
derived suppressor cells. Cancer Microenvironment, v. 6, n. 2, p. 169-
177, 2013. ISSN 1875-2292.
USHIJIMA, T.; OKOCHI‐TAKADA, E. Aberrant methylations in cancer
cells: where do they come from? Cancer Science, v. 96, n. 4, p. 206-211,
2005. ISSN 1347-9032.
VALERI, N. et al. MicroRNA-135b promotes cancer progression by
acting as a downstream effector of oncogenic pathways in colon
cancer. Cancer cell, v. 25, n. 4, p. 469-483, 2014. ISSN 1535-6108.
VAN SLUIS, R. et al. In vivo imaging of extracellular pH using 1H MRSI.
Magnetic Resonance in Medicine: An Official Journal of the International
Society for Magnetic Resonance in Medicine, v. 41, n. 4, p. 743-750,
1999. ISSN 0740-3194.
VAUPEL, P.; KALLINOWSKI, F.; OKUNIEFF, P. Blood flow, oxygen and
nutrient supply, and metabolic microenvironment of human tumors: a
review. Cancer research, v. 49, n. 23, p. 6449-6465, 1989. ISSN 0008-
5472.
VIDAL, A. F. et al. hsa-miR-29c and hsa-miR-135b differential
expression as potential biomarker of gastric carcinogenesis. World
journal of gastroenterology, v. 22, n. 6, p. 2060, 2016.
WADDINGTON, C. H. The epigenotype. Endeavour, v. 1, p. 18-20, 1942.
WALDUM, H. L.; SØRDAL, Ø.; FOSSMARK, R. Proton pump inhibitors
(PPIs) may cause gastric cancer–clinical consequences. Scandinavian
journal of gastroenterology, v. 53, n. 6, p. 639-642, 2018. ISSN 0036-
5521.
WANG, D.; DUBOIS, R. N. Prostaglandins and cancer. Gut, v. 55, n. 1, p.
115-122, 2006. ISSN 0017-5749.
WANG, F. et al. Helicobacter pylori-induced gastric inflammation and
gastric cancer. Cancer letters, v. 345, n. 2, p. 196-202, 2014. ISSN 0304-
3835.
WANG, G. et al. Up-regulation of microRNA in bladder tumor tissue is
not common. International urology and nephrology, v. 42, n. 1, p. 95-
102, 2010. ISSN 0301-1623.
WANG, J. et al. Micro RNA‐155 deficiency enhances the recruitment
and functions of myeloid‐derived suppressor cells in tumor
microenvironment and promotes solid tumor growth. International
journal of cancer, v. 136, n. 6, p. E602-E613, 2015. ISSN 0020-7136.
WANG, N. et al. miR‑ 135b inhibits tumour metastasis in prostate
cancer by targeting STAT6. Oncology letters, v. 11, n. 1, p. 543-550,
2016. ISSN 1792-1074.
WARBURG, O. On the origin of cancer cells. Science, v. 123, n. 3191, p.
309-314, 1956. ISSN 0036-8075.
WATARI, J. et al. Helicobacter pylori associated chronic gastritis, clinical
syndromes, precancerous lesions, and pathogenesis of gastric cancer
development. World Journal of Gastroenterology: WJG, v. 20, n. 18, p.
5461, 2014.
WEBSTER, R. J. et al. Regulation of epidermal growth factor receptor
signaling in human cancer cells by microRNA-7. Journal of Biological
Chemistry, v. 284, n. 9, p. 5731-5741, 2009. ISSN 0021-9258.
WHO.
Stomach
Cancer.
2012.
Disponível
em:
<
http://globocan.iarc.fr/Pages/Map.aspx >. Acesso em: 02/09/2018.
WOLFE, M. M.; SACHS, G. Acid suppression: optimizing therapy for
gastroduodenal ulcer healing, gastroesophageal reflux disease, and
stress-related erosive syndrome. Gastroenterology, v. 118, n. 2, p. S9-
S31, 2000. ISSN 0016-5085.
WOO, H. D.; KIM, J. Global DNA hypomethylation in peripheral blood
leukocytes as a biomarker for cancer risk: a meta-analysis. PloS one, v.
7, n. 4, p. e34615, 2012. ISSN 1932-6203.
WU, X.; TAN, X.; FU, S. W. May circulating microRNAs be gastric cancer
diagnostic biomarkers? Journal of Cancer, v. 6, n. 12, p. 1206, 2015.
WYNN, E. et al. Alkaline mineral water lowers bone resorption even in
calcium sufficiency:: Alkaline mineral water and bone metabolism.
Bone, v. 44, n. 1, p. 120-124, 2009. ISSN 8756-3282.
XIAO, B. et al. Induction of microRNA-155 during Helicobacter pylori
infection and its negative regulatory role in the inflammatory response.
The Journal of infectious diseases, v. 200, n. 6, p. 916-925, 2009. ISSN
1537-6613.
XIE, J. et al. miR-7 inhibits the invasion and metastasis of gastric cancer
cells by suppressing epidermal growth factor receptor expression.
Oncology reports, v. 31, n. 4, p. 1715-1722, 2014. ISSN 1021-335X.
XU, N. et al. miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells
Through Suppressing mTOR. Technology in cancer research &
treatment, v. 16, n. 6, p. 1022-1030, 2017. ISSN 1533-0346.
YAKIREVICH, E.; RESNICK, M. B. Pathology of gastric cancer and its
precursor lesions. Gastroenterology Clinics, v. 42, n. 2, p. 261-284,
2013. ISSN 0889-8553.
YANG, L. V.; CASTELLONE, R. D.; DONG, L. Targeting tumor
microenvironments for cancer prevention and therapy. In: (Ed.). Cancer
Prevention-From Mechanisms to Translational Benefits: InTech, 2012.
YANG, Y. et al. MicroRNAs as promising biomarkers for tumor-staging:
evaluation of MiR21 MiR155 MiR29a and MiR92a in predicting tumor
stage of rectal cancer. Asian Pacific journal of cancer prevention: APJCP,
v. 15, n. 13, p. 5175-5180, 2014. ISSN 1513-7368.
YU, B. et al. microRNA-29c inhibits cell proliferation by targeting NASP
in human gastric cancer. BMC cancer, v. 17, n. 1, p. 109, 2017. ISSN
1471-2407.
ZABAGLIA, L. M. Expressão de MicroRNAs e dos genes da interleucina 2
e fator de necrose tumoral e suas correlações com o H. pylori. 2017.
ZABAGLIA, L. M. et al. Expression of miRNA‐146a, miRNA‐155, IL‐2, and
TNF‐α in inflammatory response to Helicobacter pylori infection
associated with cancer progression. Annals of human genetics, v. 82, n.
3, p. 135-142, 2018. ISSN 0003-4800.
ZHANG, J. et al. MiR-29c mediates epithelial-to-mesenchymal
transition in human colorectal carcinoma metastasis via PTP4A and
GNA13 regulation of β-catenin signaling. Annals of oncology, v. 25, n.
11, p. 2196-2204, 2014. ISSN 1569-8041.
ZHOU, X. et al. MicroRNA-7 inhibits tumor metastasis and reverses
epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by
targeting EGFR in epithelial ovarian cancer. PLoS One, v. 9, n. 5, p.
e96718, 2014. ISSN 1932-6203.
ZONARI, E. et al. A role for miR-155 in enabling tumor-infiltrating innate
immune cells to mount effective anti-tumor responses. Blood, p. blood-
2012-08-449306, 2013. ISSN 0006-4971.
Dans le document
The DART-Europe E-theses Portal
(Page 97-102)